SLC29A1 and neoplasm: Our findings demonstrate that SC is a potent anti-tumor agent that not only reduces proliferation and induces apoptosis in resistant cells, but may also enhance the effectiveness of cytarabine by increasing the expression of ENT1 (equilibrium nucleoside transporter 1) and dCK (deoxycytidine kinase).